Kimberly-Clark Third Quarter 2026 Earnings Conference Call - KIMBERLY CLARK CORP

Financial Performance:

• Completed the acquisition of Tenview, creating a combined entity at the intersection of FMCG and healthcare.
• Q3 2026 organic growth was solid, driven by durable operating models overcoming one-off headwinds.
• North America tissue and KC Professional showed share gains; Personal Care performed well in international focus markets (South Korea, Brazil, Indonesia).
• Self-care and essential care brands (Tenview legacy) grew 3% organically, with a significant turnaround from a "red" scorecard to 70% "green" performance.
• Full-year gross inflationary impact projected at ~$250 million ($50M in Q2, $200M in H2), partially offset by 6.1% gross productivity gains.
• Pricing expected to be relatively flat for the full year, with Q4 benefiting from easier comparisons and reduced promotional intensity vs. Q4 prior year.

Guidance and Future Outlook:

• Maintaining fiscal 2026 guidance for standalone Kimberly-Clark (KC), reflecting strong underlying momentum and Q4 commercial agenda.
• 2027 Outlook: Projected adjusted EPS dilution of mid-single digits (vs. standalone KC) due to transaction integration and amortization, with a snapback expected in 2028.
• Long-term goal is mid-to-high single-digit EPS growth on a two-year compounded basis (2026-2028) vs. standalone KC baseline.
• Revenue synergies are viewed as transformation opportunities rather than guaranteed short-term earnings contributors; focus remains on cost synergies of ~$1.9 billion.
• 2027 priorities: Deliver cost synergies, strengthen core businesses, and seed future growth through targeted investments.

Business Segments and Product Lines:

• Integration: Executing a "Ready, Set, Grow" three-phase plan; "Ready" phase focuses on seamless Day 1 operations, staffing, and quick wins.
• Tenview Brands: OTC (Tylenol up mid-single digits, Zyrtec up 5%, Rinzal up 7%), Hair (Rogaine up 30%, OGX performing well), and Essential Care (Baby up 5%, Band-Aid up 4%) showing strong momentum.
• Kimberly-Clark Brands: North America Tissue performing strongly (+20 bps share); Baby Care impacted by club distribution changes and a false social media crisis; Oral Care and Skincare facing execution challenges requiring assortment and creative resets.
• Product Launches: New "Big Dreams" diapers launched in partnership with Amazon targeting value-conscious consumers; new product launches delayed to early 2027 due to quality control on new manufacturing assets.

Market and Competitive Landscape:

• China: Business stabilized after false safety allegations; government confirmed product safety, but consumer trust recovery is gradual; aiming to regain ~20% market leadership share lost over two years of promotional pressure.
• North America: Club distribution changes caused temporary headwinds in diapers; underlying demand remains healthy despite pricing pressure.
• Global Expansion: Identified distribution gaps in Europe (KC personal care) and India (KC entered via Tenview's existing multi-million point distribution); potential to leverage Tenview's infrastructure for KC brands.
• Competition: Intense promotional environment in diapers with lower-priced entrants; strategy focuses on "best product at lowest cost" to maintain premium mix (now >85% of business).

Risks and Challenges:

• Social Media Crisis: False allegations in China significantly impacted demand, requiring time to rebuild trust despite regulatory clearance.
• Execution Risks: Skincare and Oral Care underperformance in Tenview legacy brands requires immediate portfolio rationalization and marketing improvements.
• Integration Complexity: Managing two distinct leadership teams, systems (separate SAP instances), and cultures while maintaining operational continuity.
• Cost Pressures: Elevated spot freight rates in North America contributing to Q3/H2 inflation headwinds.

Management Commentary and Tone:

• Tone: Confident, execution-focused, and optimistic about the "generational opportunity" despite near-term integration challenges.
• Leadership: New operating model implemented Monday; leadership assessments completed for both legacy and Tenview teams.
• Strategic Philosophy: Emphasizes a "flywheel" growth model where cost synergies fund brand reinvestment; committed to long-term value over short-term earnings management.
• Priorities: Focus on "boring" execution (shipping, paying suppliers/staff) to ensure seamless integration; plans for staffing changes in 2027.

Analyst Questions and Answers:

• Morgan Stanley (Dara): Asked about Q4 assumptions and 2027 dilution/synergies. Management confirmed confidence in 2026 guidance and explained 2027 dilution is driven by amortization and reinvestment, with a recovery path in 2028.
• UBS (Peter Grom): Inquired about North America health. Management cited inventory changes (-130 bps), postponed launches, and club distribution shifts as key Q3 headwinds, expecting improvement in Q4/2027.
• Piper Sandler (Michael Lavery): Asked about Tenview brand health. Management noted 100% executional (not structural) issues previously; highlighted strong OTC/Hair performance but identified Skincare/Oral Care needing assortment/creative resets.
• Wells Fargo (Chris Carey): Asked about leadership stability (Russ Torres departure) and financial modeling. Management confirmed new team readiness, clarified 2027 dilution is against standalone KC, and explained non-GAAP treatment of amortization.
• Evercore (Javier Escalante): Queried diaper dynamics in US/China and 11/11 sales. Management detailed China trust rebuilding efforts and North America share gains outside of clubs; noted 11/11 pipeline was already set pre-crisis.
• Bank of America (Anna Lizell): Asked about "Big Dreams" launch and inflation. Confirmed Amazon partnership for value-tier diapers; provided $250M full-year inflation guidance offset by productivity.
• TD (Robert Moscow): Challenged revenue synergy targets. Management clarified $1.9B target is cost-only; revenue synergies are transformational and reinvestment-heavy ($300M reinvested for $200M EBIT impact).
• Canaccord Genuity (Susan Anderson): Asked about retailer inventory levels. Management stated inventory is within normal ranges; expects optimization through improved service levels post-integration.

Other Key Points:

• Synergy Breakdown: $1.9B target comprises: 1/3 from overhead/G&A optimization (including staffing changes), ~30-40% from COGS (supply chain/procurement), and remainder from sales/marketing/trade spend.
• System Integration: KC SAP S4 ERP systems will be phased in for Tenview businesses; interim reporting via Power BI.
• Joint Venture: Arbex JV (with Susana) launched July 1, showing strong early value creation through cost management.
• Next Update: Detailed synergy cadence and Cagney update expected in early 2027.